Abbott Secures Conditional EU Approval for Solvay Drugs Acquisition

09:34 AM | February 12, 2010 | Natasha Alperowicz

Abbott Laboratories has secured conditional EU approval for the acquisition of the drug unit of Solvay. Abbott will need to divest the cystic fibrosis testing business of Solvay pharma's subsidiary...